Scilex Holding (SCLXW) Receivables - Net (2021 - 2026)
Scilex Holding (SCLXW) recorded quarterly Receivables - Net of $19.2 million in Q1 2026, up 60.79% quarter-over-quarter from $11.9 million in Q3 2025, and up 80.81% on a YoY basis from $10.6 million in Q1 2025.
Scilex Holding (SCLXW) Receivables - Net (2021 - 2026) Analysis & Trends
Scilex Holding's Receivables - Net history runs 6 years deep, the most recent figure standing at $19.2 million for Q1 2026.
- In Q1 2026, Receivables - Net rose 80.81% year-over-year to $19.2 million; the TTM figure through Mar 2026 stood at $19.2 million (up 80.81% YoY), while the FY2024 annual figure was $26.4 million, up 726.31% from the prior year.
- Receivables - Net was $19.2 million for Q1 2026 at Scilex Holding, up from $11.9 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $38.0 million in Q2 2024 to a low of $3.2 million in Q1 2023.
- Historically, Receivables - Net has averaged $22.1 million across 5 years, with a median of $21.2 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net surged 828.63% in 2024, then sank 64.27% in 2025.
- A 5-year view of Receivables - Net shows it stood at $21.2 million in 2022, then jumped by 62.92% to $34.6 million in 2023, then decreased by 23.57% to $26.4 million in 2024, then slumped by 54.84% to $11.9 million in 2025, then soared by 60.79% to $19.2 million in 2026.
- The last three Receivables - Net figures came in at $19.2 million (Q1 2026), $11.9 million (Q3 2025), and $16.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Scilex Holding | - | - | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.20 Mn |
| Mar 31, 2026 | 19.20 Mn |
| Sep 30, 2025 | 11.94 Mn |
| Sep 30, 2025 | 11.94 Mn |
| Jun 30, 2025 | 16.77 Mn |
| Jun 30, 2025 | 16.77 Mn |
| Mar 31, 2025 | 10.62 Mn |
| Mar 31, 2025 | 10.62 Mn |
| Dec 31, 2024 | 26.44 Mn |
| Dec 31, 2024 | 26.44 Mn |
| Sep 30, 2024 | 31.58 Mn |
| Sep 30, 2024 | 31.58 Mn |
| Jun 30, 2024 | 38.00 Mn |
| Jun 30, 2024 | 38.00 Mn |
| Mar 31, 2024 | 29.72 Mn |
| Mar 31, 2024 | 29.72 Mn |
| Dec 31, 2023 | 34.60 Mn |
| Dec 31, 2023 | 34.60 Mn |
| Sep 30, 2023 | 16.43 Mn |
| Sep 30, 2023 | 16.43 Mn |